Dopamine versus dobutamine in very low birthweight infants: endocrine effects. Export

@article{citeulike:2470019, abstract = {OBJECTIVES: To compare the endocrine effects of dopamine and dobutamine in hypotensive very low birthweight (VLBW) infants. DESIGN: Non-blinded randomised prospective trial. SETTING: Level III neonatal intensive care unit. PATIENTS: 35 hypotensive VLBW infants who did not respond to volume loading, assigned to receive dopamine or dobutamine. Measurements: Haemodynamic variables and serum levels of thyroid stimulating hormone (TSH), total thyroxine (T(4)), prolactin (PRL) and growth hormone were assessed during the first 72 h of treatment and the first 72 h after stopping treatment. RESULTS: Demographic and clinical data did not significantly differ between the two groups. Necessary cumulative and mean drug doses and maximum infusion required to normalise blood pressure were significantly higher in the dobutamine than in the dopamine group (p<0.01). Suppression of TSH, T(4) and PRL was observed in dopamine-treated newborns from 12 h of treatment onwards, whereas levels of growth hormone reduced significantly only at 12 h and 36 h of treatment (p<0.01). TSH, T(4) and PRL rebound was observed from the first day onwards after stopping dopamine. Dobutamine administration did not alter the profile of any of the hormones and no rebound was observed after stopping treatment. CONCLUSION: Dopamine and dobutamine both increase the systemic blood pressure, though dopamine is more effective. Dopamine reduces serum levels of TSH, T(4) and PRL in VLBW infants but such suppression is quickly reversed after treatment is stopped. Further research is required to assess if short-term iatrogenic pituitary suppression has longer-term consequences.}, address = {Neonatal Intensive Care Unit, Department of Critical Care Medicine, Meyer University Hospital, via L. Giordano, 13 I-50132 Florence, Italy. filippi.luca@virgilio.it}, author = {Filippi, L. and Pezzati, M. and Poggi, C. and Rossi, S. and Cecchi, A. and Santoro, C.}, citeulike-article-id = {2470019}, citeulike-linkout-0 = {http://dx.doi.org/10.1136/adc.2006.098566}, citeulike-linkout-1 = {http://fn.bmj.com/cgi/content/abstract/92/5/F367}, citeulike-linkout-2 = {http://view.ncbi.nlm.nih.gov/pubmed/17329276}, citeulike-linkout-3 = {http://www.hubmed.org/display.cgi?uids=17329276}, doi = {10.1136/adc.2006.098566}, issn = {1359-2998}, journal = {Arch Dis Child Fetal Neonatal Ed}, keywords = {clinical, dobutamine, dopamine, endocrine, infants, thyroid}, month = {September}, number = {5}, posted-at = {2008-07-28 20:51:13}, priority = {2}, title = {Dopamine versus dobutamine in very low birthweight infants: endocrine effects.}, url = {http://dx.doi.org/10.1136/adc.2006.098566}, volume = {92}, year = {2007} }

TY - JOUR ID - citeulike:2470019 L3 - citeulike-article-id:2470019 N2 - OBJECTIVES: To compare the endocrine effects of dopamine and dobutamine in hypotensive very low birthweight (VLBW) infants. DESIGN: Non-blinded randomised prospective trial. SETTING: Level III neonatal intensive care unit. PATIENTS: 35 hypotensive VLBW infants who did not respond to volume loading, assigned to receive dopamine or dobutamine. Measurements: Haemodynamic variables and serum levels of thyroid stimulating hormone (TSH), total thyroxine (T(4)), prolactin (PRL) and growth hormone were assessed during the first 72 h of treatment and the first 72 h after stopping treatment. RESULTS: Demographic and clinical data did not significantly differ between the two groups. Necessary cumulative and mean drug doses and maximum infusion required to normalise blood pressure were significantly higher in the dobutamine than in the dopamine group (p<0.01). Suppression of TSH, T(4) and PRL was observed in dopamine-treated newborns from 12 h of treatment onwards, whereas levels of growth hormone reduced significantly only at 12 h and 36 h of treatment (p<0.01). TSH, T(4) and PRL rebound was observed from the first day onwards after stopping dopamine. Dobutamine administration did not alter the profile of any of the hormones and no rebound was observed after stopping treatment. CONCLUSION: Dopamine and dobutamine both increase the systemic blood pressure, though dopamine is more effective. Dopamine reduces serum levels of TSH, T(4) and PRL in VLBW infants but such suppression is quickly reversed after treatment is stopped. Further research is required to assess if short-term iatrogenic pituitary suppression has longer-term consequences. IS - 5 JF - Arch Dis Child Fetal Neonatal Ed SN - 1359-2998 AD - Neonatal Intensive Care Unit, Department of Critical Care Medicine, Meyer University Hospital, via L. Giordano, 13 I-50132 Florence, Italy. filippi.luca@virgilio.it TI - Dopamine versus dobutamine in very low birthweight infants: endocrine effects. VL - 92 KW - clinical KW - dobutamine KW - dopamine KW - endocrine KW - infants KW - thyroid AU - Filippi, L AU - Pezzati, M AU - Poggi, C AU - Rossi, S AU - Cecchi, A AU - Santoro, C PY - 2007/09// UR - http://dx.doi.org/10.1136/adc.2006.098566 ER -